TradingKey

关于 Elanco Animal Health Inc 公司

Elanco Animal Health Incorporated 是一家动物保健公司。该公司专注于提供产品和服务，以预防和治疗农场动物和宠物的疾病。其多样化、耐用的产品组合服务于许多物种的动物，主要包括：狗、猫和牛、家禽、猪和羊。该公司提供两大类产品：宠物保健和农场动物。其宠物保健产品组合专注于杀虫剂、疫苗和治疗剂。其宠物保健产品组合包括保护宠物免受跳蚤、蜱虫和体内寄生虫侵害的产品。其农场动物产品组合主要针对牛、猪和家禽。其宠物保健产品包括 Advantage Family、Atopica、Claro/ Neptra、Credelio Family、Drontal Family、Galliprant、Interceptor Plus、Milbemax、Onsior、Seresto、Trifexis 和 TruCan。其农场动物产品包括 AviPro、Baycox、Catosal、Comforta、Denagard、Experior、Hemicell、Maxiban、Monteban、Pulmotil、Rumensin 等。

公司简介

公司代码ELAN

公司名称Elanco Animal Health Inc

上市日期Sep 20, 2018

CEOMr. Jeffrey N. (Jeff) Simmons

员工数量9000

证券类型Ordinary Share

年结日Sep 20

公司地址2500 Innovation Way N

城市GREENFIELD

上市交易所NYSE Consolidated

国家United States of America

邮编46140-9163

电话18773526261

网址https://www.elanco.com/

公司代码ELAN

上市日期Sep 20, 2018

CEOMr. Jeffrey N. (Jeff) Simmons

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

150.03K

+26.80%

Mr. Michael J. Harrington

Independent Director

99.26K

--

Mr. Art A. Garcia, CPA

Independent Director

80.96K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

Dr. Deborah Turner Kochevar, Ph.D.

Independent Director

79.40K

--

Mr. Paul S. Herendeen

Independent Director

74.50K

--

Mr. James Meer

Senior Vice President, Chief Accounting Officer

62.55K

-1.82%

Ms. Shiv O'Neill

Executive Vice President, General Counsel, Corporate Secretary

53.92K

+100.82%

名称

名称/职务

职务

持股

持股变动

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

150.03K

+26.80%

Mr. Michael J. Harrington

Independent Director

99.26K

--

Mr. Art A. Garcia, CPA

Independent Director

80.96K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Pet Health

635.00M

53.23%

Farm Animal

546.00M

45.77%

Contract Manufacturing

12.00M

1.01%

地区USD

名称

营收

占比

International

639.00M

53.56%

United States

554.00M

46.44%

业务

地区

业务USD

名称

营收

占比

Pet Health

635.00M

53.23%

Farm Animal

546.00M

45.77%

Contract Manufacturing

12.00M

1.01%

股东统计

更新时间: 5月16日周五

持股股东

股东类型

持股股东

占比

Dodge & Cox

16.70%

PRIMECAP Management Company

10.11%

The Vanguard Group, Inc.

9.69%

Fidelity Management & Research Company LLC

7.71%

Black Creek Investment Management, Inc.

4.44%

Other

51.35%

持股股东

占比

Dodge & Cox

16.70%

PRIMECAP Management Company

10.11%

The Vanguard Group, Inc.

9.69%

Fidelity Management & Research Company LLC

7.71%

Black Creek Investment Management, Inc.

4.44%

Other

51.35%

股东类型

持股股东

占比

Investment Advisor

63.16%

Investment Advisor/Hedge Fund

32.92%

Hedge Fund

3.35%

Individual Investor

1.08%

Research Firm

1.01%

Sovereign Wealth Fund

0.79%

Pension Fund

0.77%

Bank and Trust

0.44%

Family Office

0.11%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

879

514.22M

103.54%

-39.32M

2025Q1

974

511.32M

102.96%

-71.50M

2024Q4

996

503.77M

101.85%

-80.73M

2024Q3

1000

494.48M

100.04%

-96.31M

2024Q2

1034

494.94M

100.16%

-92.98M

2024Q1

1051

494.01M

100.22%

-99.13M

2023Q4

1048

492.96M

100.04%

-103.67M

2023Q3

1055

493.54M

100.18%

-93.98M

2023Q2

1067

490.17M

99.54%

-75.35M

2023Q1

1071

498.03M

101.25%

-46.19M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Dodge & Cox

82.92M

16.7%

-260.08K

-0.31%

Mar 31, 2025

PRIMECAP Management Company

50.22M

10.11%

-941.63K

-1.84%

Mar 31, 2025

The Vanguard Group, Inc.

48.14M

9.69%

-437.73K

-0.90%

Mar 31, 2025

Fidelity Management & Research Company LLC

38.30M

7.71%

+9.79M

+34.35%

Mar 31, 2025

Black Creek Investment Management, Inc.

22.04M

4.44%

+1.61M

+7.87%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

20.46M

4.12%

+2.56M

+14.32%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

20.06M

4.04%

-618.85K

-2.99%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

15.98M

3.22%

+292.65K

+1.87%

Mar 31, 2025

Fidelity Institutional Asset Management

15.55M

3.13%

+3.83M

+32.70%

Mar 31, 2025

Shapiro Capital Management LLC

12.33M

2.48%

-24.38K

-0.20%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

SPDR S&P Pharmaceuticals ETF

3.83%

iShares U.S. Pharmaceuticals ETF

3.57%

First Trust Health Care Alphadex Fund

3.03%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

2.72%

First Trust NASDAQ Pharmaceuticals ETF

2.36%

Brandes US Small-Mid Cap Value ETF

2.14%

VanEck Agribusiness ETF

1.51%

First Trust Mid Cap Value AlphaDEX Fund

0.98%

Global X Adaptive US Factor ETF

0.72%

Federated Hermes MDT Large Cap Value ETF

0.7%

SPDR S&P Pharmaceuticals ETF

占比3.83%

iShares U.S. Pharmaceuticals ETF

占比3.57%

First Trust Health Care Alphadex Fund

占比3.03%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

占比2.72%

First Trust NASDAQ Pharmaceuticals ETF

占比2.36%

Brandes US Small-Mid Cap Value ETF

占比2.14%

VanEck Agribusiness ETF

占比1.51%

First Trust Mid Cap Value AlphaDEX Fund

占比0.98%

Global X Adaptive US Factor ETF

占比0.72%

Federated Hermes MDT Large Cap Value ETF

占比0.7%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Elanco Animal Health Inc

13.975USD

Elanco Animal Health Inc

13.975

概览

公司

财务